Wordt geladen...
TYPE 2 DIABETES AND CARDIOVASCULAR COMPLICATIONS: IS IT POSSIBLE TO IMPROVE PROGNOSIS BY GLUCOSE LOWERING THERAPY?
Regardless the fact that type 2 diabetes (DM2) is related to higher risk of cardiovascular diseases (CVD) development and complications, incl. heart failure (HF), usage of the most of glucose lowering drugs (GLD) does not only improve life prognosis, but might increase the risk of HF. Inhibitors of...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Russo |
| Gepubliceerd in: |
«FIRMA «SILICEA» LLC
2018-09-01
|
| Reeks: | Российский кардиологический журнал |
| Onderwerpen: | |
| Online toegang: | https://russjcardiol.elpub.ru/jour/article/view/2918 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|